Table 2

Data representing the basic histological characteristics and quantified immunohistochemistry of tissue viability in format p50 (p25–p75)

RCR 0 weeksRCR 7 weeksGCI 0 weeksGCI 7 weeks
Median vessel count0.05 (0–0.35)**†1.04 (0.78–1.23)**0.36 (0.24–0.38)†0.42 (0.34–0.60)
Median nuclei count8.5 (2.7–16.6)**26.7 (21.5–45.2)**13.8 (10.9–16.9)16.5 (12.1–26.1)
Median SD of nuclei count6.7 (2.6–12.9)**20.4 (16.1–26.0)**11.1 (7.5–15.4)12.2 (9.1–16.1)
Median cell nuclear area (%)0.12 (0.09–0.14)0.12 (0.09–0.14)0.11 (0.07–0.13)0.11 (0.09–0.13)
Proliferation (% PCNA staining per cell)0.07 (0.01–0.21)*0.42 (0.23–0.58)*0.05 (0.02–0.12)0.06 (0.03–0.08)
p53 (% staining per cell)0.01 (0.001–0.02)*0.22 (0.09–0.22)*0.03 (0.01–0.1)*0.08 (0.02–0.23)*
HIF-1α (% staining per cell)0.03 (0.01–0.09)*0.11 (0.02–0.40)*0.05 (0.03–0.09)0.09 (0.04–0.13)
VEGF (% staining per cell)0.41 (0.12–0.74)†0.22 (0.12–1.17)0.08 (0.04–0.14)†0.13 (0.03–0.30)
  • *p<0.05; **p<0.01 (between 0-week and 7-week groups).

  • †p<0.05 (between RCR 0 and GCI 0 weeks).

  • GCI, glucocorticoid injection; HIF-1α, hypoxia inducible fatcor 1α; PCNA, proliferating cell nuclear antigen; RCR, rotator cuff repair.